Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4Unspecified Adult Solid Tumor, Protocol Specific 2Uterine Cervical Neoplasms 1Sarcoma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1Adenoma, Islet Cell 1

Interventions

Sunitinib 4Everolimus 4Fluorouracil 3Temozolomide 2Streptozocin 2Octreotide 2Leucovorin 2Irinotecan 2sargramostim 1sapanisertib 1pasireotide 1napabucasin 1motesanib diphosphate 1montanide ISA 51 1irinotecan sucrosofate 1incomplete Freund's adjuvant 1ibrutinib 1ganitumab 1cabozantinib 1batifiban 1aflibercept 1Wound Healing 1Thalidomide 1Taxes 1Sorafenib 1Salts 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenoma, Islet Cell × Endostatins × Clear all
NCT01845675 2017-04-13

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

Peking Union Medical College Hospital

Phase 2 Completed
14 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡